{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:48:06Z","timestamp":1791809286575,"version":"4.3.4"},"reference-count":34,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1308.070071","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T16:13:27Z","timestamp":1336580007000},"page":"1144-1149","source":"Crossref","is-referenced-by-count":137,"title":["Risk Factors for Colonization with Extended-Spectrum \u03b2-Lactamase\u2013producing Bacteria and Intensive Care Unit Admission"],"prefix":"10.3201","volume":"13","author":[{"given":"Anthony D.","family":"Harris","sequence":"first","affiliation":[{"name":"University of Maryland, Baltimore, Maryland, USAVeterans Affairs Maryland Health Care System, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessina C.","family":"McGregor","sequence":"additional","affiliation":[{"name":"University of Maryland, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"University of Maryland, Baltimore, Maryland, USAVeterans Affairs Maryland Health Care System, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Strauss","sequence":"additional","affiliation":[{"name":"University of Maryland, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C.","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Maryland, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold C.","family":"Standiford","sequence":"additional","affiliation":[{"name":"University of Maryland Medical Center, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan N.","family":"Hebden","sequence":"additional","affiliation":[{"name":"University of Maryland Medical Center, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"J. Glenn","family":"Morris","sequence":"additional","affiliation":[{"name":"University of Maryland, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2007,8]]},"reference":[{"key":"key-10.3201\/eid1308.070071-201205090400-R1","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.","volume":"32","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R2","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.amjmed.2006.03.013","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae.","volume":"119","author":"Paterson","year":"2006","journal-title":"Am J Med"},{"key":"key-10.3201\/eid1308.070071-201205090400-R3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/420816","article-title":"Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.","volume":"39","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jac\/dkl199","article-title":"In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).","volume":"58","author":"Rossi","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1308.070071-201205090400-R5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"Data summary from January 1992 through June 2004, issued October 2004.","volume":"32","author":"National Nosocomial Infections Surveillance (NNIS) System Report","year":"2004","journal-title":"Am J Infect Control"},{"key":"key-10.3201\/eid1308.070071-201205090400-R6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1086\/502575","article-title":"Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.","volume":"26","author":"Blot","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3201\/eid1110.050508","article-title":"Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization.","volume":"11","author":"Furuno","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1086\/502358","article-title":"Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase\u2013producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program.","volume":"25","author":"Harris","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0195-6701(97)90163-8","article-title":"Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit.","volume":"35","author":"Pena","year":"1997","journal-title":"J Hosp Infect"},{"key":"key-10.3201\/eid1308.070071-201205090400-R10","unstructured":"Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement (M100\u2013S16). Wayne (PA): the Institute; 2006."},{"key":"key-10.3201\/eid1308.070071-201205090400-R11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","article-title":"A chronic disease score from automated pharmacy data.","volume":"45","author":"Von Korff","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jclinepi.2006.01.016","article-title":"Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections.","volume":"59","author":"McGregor","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/503016","article-title":"Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions.","volume":"27","author":"Lipworth","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/clinids\/23.1.118","article-title":"Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center.","volume":"23","author":"Rice","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1086\/513953","article-title":"Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.","volume":"26","author":"Bartlett","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.3201\/eid1308.070071-201205090400-R18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-142-3-200502010-00006","article-title":"Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.","volume":"142","author":"Carratala","year":"2005","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1308.070071-201205090400-R20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jama.283.6.749","article-title":"A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.","volume":"283","author":"Marrie","year":"2000","journal-title":"JAMA"},{"key":"key-10.3201\/eid1308.070071-201205090400-R21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-136-11-200206040-00013","article-title":"The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida.","volume":"136","author":"Safdar","year":"2002","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1308.070071-201205090400-R22","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase\u2013producing Enterobacteriaceae.","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1308.070071-201205090400-R23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/jac\/45.6.895","article-title":"Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns.","volume":"45","author":"Saurina","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1308.070071-201205090400-R24","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","article-title":"Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.","volume":"343","author":"Donskey","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1308.070071-201205090400-R25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1086\/314874","article-title":"Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.","volume":"180","author":"Donskey","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R26","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1086\/647041","article-title":"Natural history of colonization with vancomycin-resistant Enterococcus faecium.","volume":"16","author":"Montecalvo","year":"1995","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R27","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/archinte.159.13.1467","article-title":"Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period.","volume":"159","author":"Ostrowsky","year":"1999","journal-title":"Arch Intern Med"},{"key":"key-10.3201\/eid1308.070071-201205090400-R28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1086\/647823","article-title":"Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection.","volume":"19","author":"Chang","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0195-6701(97)90071-2","article-title":"Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA.","volume":"37","author":"Coello","year":"1997","journal-title":"J Hosp Infect"},{"key":"key-10.3201\/eid1308.070071-201205090400-R30","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1086\/345921","article-title":"Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak?","volume":"186","author":"Gardam","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1086\/502305","article-title":"Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations.","volume":"25","author":"Thouverez","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid1308.070071-201205090400-R32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1086\/500936","article-title":"Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital.","volume":"42","author":"Ben-Ami","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1308.070071-201205090400-R33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988.","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"key-10.3201\/eid1308.070071-201205090400-R34","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1128\/JCM.00756-06","article-title":"Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.","volume":"44","author":"Moland","year":"2006","journal-title":"J Clin Microbiol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/13\/8\/07-0071_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:23:40Z","timestamp":1732631020000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/13\/8\/07-0071_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2007,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1308.070071","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}